FDA Inspection 1311062 - New York Blood Center Enterprises - April 03, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on April 3, 2026, issued by the New York District Office, covering biologics.

Company: New York Blood Center Enterprises
Inspection Date: April 3, 2026
Product Type: Biologics
Office: New York District Office

Open in Dashboard

ID · 044a9fd6-4493-4d21-a1cf-9c768fb3add1

Violation Codes8

21 CFR 600.1521 CFR 606.100(b)21 CFR 606.160(a)(1)21 CFR 606.160(b)21 CFR 606.17121 CFR 606.20(b)21 CFR 606.65(e)21 CFR 640.15(a)

Full citation text and observation details available on the Dashboard.